BenjaminAviDermanMD
Hematology • Chicago, ILHematologic Oncology
Assistant Professor at the University of Chicago
Dr. Derman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5758 S. Maryland Ave.
Chicago, IL 60637
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2017 - 2020
Rush University Medical CenterChief Residency, Internal Medicine, 2016 - 2017- Rush University Medical CenterResidency, Internal Medicine, 2013 - 2016
Northwestern University The Feinberg School of MedicineClass of 2013
Certifications & Licensure
IL State Medical License 2013 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Start of enrollment: 2023 May 30
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsATTR Cardiomyopathy Meets Multiple Myeloma: The Importance of Cardiac BiopsyAnthony J. Kanelidis, Patrick Miller, Nicole Prabhu, Mark Joshua Dela Cruz, Francis J. Alenghat
JACC. Cardiooncology. 2021-10-01 - 10 citationsRecommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy.Benjamin A. Derman, Andrew M. Davis
JAMA. 2021-09-21 - 6 citationsKnowing the unknowns in high risk multiple myeloma.Benjamin A. Derman, Satyajit Kosuri, Andrzej Jakubowiak
Blood Reviews. 2021-08-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
